Press Release: Common Sensing : Common Sensing Gocap Reveals Insulin Adherence Effects on Glycemic Control
BOSTON, April 16, 2019 /PRNewswire/ -- Common Sensing, the evidence-based, data-driven injectable medicine company, today announced the publication of new evidence supporting the use of Gocap , their IP-protected injection monitoring platform. The results, published in Diabetes Care's...
Read full article »
Common Sensing develops and manufactures smart insulin pen caps that records and manages the insulin intake level of diabetes patients.
Read more